A phase IIa trial of very low dose cyclobenzaprine in patients with fibromyalgia.
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2011
At a glance
- Drugs Cyclobenzaprine (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Krele Pharmaceuticals Inc; Tonix Pharmaceuticals Inc
- 07 Sep 2011 Status changed to completed, according to results published in a TONIX Pharmaceuticals media release.
- 01 Sep 2011 Results published in The Journal of rheumatology.
- 17 Jun 2011 Results have been presented at the Associated Professional Sleep Society 2011 Anniversary Meeting according to a TONIX Pharmaceuticals media release. Results were also reported in the media release.